Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Lucas A. Horn(National Institutes of Health), Claudia Palena(National Cancer Institute)
Journal for ImmunoTherapy of Cancer
March 1, 2020
Cited by 96


Related Papers